Picture of Tianda Pharmaceuticals logo

455 Tianda Pharmaceuticals Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Tianda Pharmaceuticals, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue362527491474510
Cost of Revenue
Gross Profit270424361259241
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses332501475501537
Operating Profit29.926.216.3-26.9-27.3
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes29.926.215.9-27.4-28
Provision for Income Taxes
Net Income After Taxes22.2168.8-25.9-21.7
Minority Interest
Net Income Before Extraordinary Items
Net Income102.663.14-27.1-19.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income102.663.14-27.1-19.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.0050.0010.002-0.013-0.012
Dividends per Share
Special Dividends per Share